Blood Safety: Recalls and Withdrawals of Plasma Products
T-HEHS-98-166
Published: May 07, 1998. Publicly Released: May 07, 1998.
Skip to Highlights
Highlights
GAO discussed the amount of plasma products, and in particular the amount of intravenous immune globulin (IVIG), that was being lost due to removal of products from the market, focusing on the: (1) number of recent product recalls and withdrawals; (2) reasons for these actions; (3) different types of plasma products affected; (4) amount of product that has been returned as a result of these actions; and (5) current shortage of IVIG of reducing the number of donors for each plasma product.
Full Report
Office of Public Affairs
Topics
Health care servicesHealth hazardsMedical suppliesNeurological diseasesProduct recallsProduct safetyVaricellaFinancial derivativesPublic healthSurgery